Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (421-430 of 754) with videos related to

Pageof 76
Sort By:
Neuro-Oncology|July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumorsRoberta Rudà, David Capper, Adam D Waldman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]Jonas Ecker, Florian Selt, Dominik Sturm, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 18, 2015
Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entitiesAndrey Korshunov, Frederick A Jakobiec, Charles G Eberhart, et al.
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomasAnat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric MedulloblastomaRyuma Tanaka, Banlanjo Umaru, Matthew Sobo, et al.
Nature Communications|March 9, 2018
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesisPaola Infante, Roberta Faedda, Flavia Bernardi, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Neuro-Oncology|November 11, 2020
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastomaThomas K Albert, Marta Interlandi, Martin Sill, et al.
International Journal of Cancer|April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsisUmar Khalid, Milena Simovic, Linda A Hammann, et al.
Pageof 76

Showing results (421-430 of 754) with videos related to

Sort By:
Pageof 76
Neuro-Oncology|July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumorsRoberta Rudà, David Capper, Adam D Waldman, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84]Jonas Ecker, Florian Selt, Dominik Sturm, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|July 18, 2015
Comparative integrated molecular analysis of intraocular medulloepitheliomas and central nervous system embryonal tumors with multilayered rosettes confirms that they are distinct nosologic entitiesAndrey Korshunov, Frederick A Jakobiec, Charles G Eberhart, et al.
Acta Neuropathologica|April 22, 2010
Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettesAndrey Korshunov, Marc Remke, Marco Gessi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2013
PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomasAnat Erdreich-Epstein, Nathan Robison, Xiuhai Ren, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
<i>hTERT</i> Expression, Regulation, and Prognostic Significance in Pediatric MedulloblastomaRyuma Tanaka, Banlanjo Umaru, Matthew Sobo, et al.
Nature Communications|March 9, 2018
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesisPaola Infante, Roberta Faedda, Flavia Bernardi, et al.
Acta Neuropathologica|November 20, 2012
LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR)Andrey Korshunov, Marina Ryzhova, David T W Jones, et al.
Neuro-Oncology|November 11, 2020
An extracellular vesicle-related gene expression signature identifies high-risk patients in medulloblastomaThomas K Albert, Marta Interlandi, Martin Sill, et al.
International Journal of Cancer|April 12, 2022
A synergistic interaction between HDAC- and PARP inhibitors in childhood tumors with chromothripsisUmar Khalid, Milena Simovic, Linda A Hammann, et al.
Pageof 76